The mechanistic evidence sits with the individual peptides, strongest for GHK-Cu
On average, volunteers in the retatrutide clinical trial who received the study drug rather than a placebo lost an average of 70.3 pounds over about a year-and-a-half, with more than 45% of participants losing more than 30% of their body weight
Fine-tuning the gastrointestinal environment
Studies show reduced edema, decreased inflammation, preserved hair follicles, enhanced granulation tissue formation, and faster re-epithelialization in BPC-157-treated burns
Selank was developed by researchers at the Institute of Molecular Genetics in Russia in the 1980s, and it has
Animal Crossing and COVID-19: A Qualitative Study Examining How Video Games Satisfy Basic Psychological Needs During the Pandemic